NCT06325098View on ClinicalTrials.gov

Implementation of a Diagnostic Workflow for Personalized Diagnosis of Nephrotic Syndrome

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 26, 2022

Primary Completion Date

January 31, 2026

Study Completion Date

June 30, 2026

Conditions
Nephrotic Syndrome
Interventions
DIAGNOSTIC_TEST

Anti-nephrin antibodies

Assessment of anti-nephrin antibodies on serum samples and in vitro study of permeabilizing effect on 3D organ-on-a-chip models and STED microscopy on healthy human kidneys.

DIAGNOSTIC_TEST

u-RPC cultures

Urine sample collection for u-RPC cultures

Trial Locations (1)

Unknown

RECRUITING

Meyer Children's Hospital IRCCS, Florence

All Listed Sponsors
lead

Meyer Children's Hospital IRCCS

OTHER